NFCR Archives - Page 4 of 4 - NFCR


Minor League Baseball and Play4TheCure

For the second year in a row, Play4TheCure and minor league baseball are teaming up this summer to raise money and awareness for cutting-edge cancer research. The program was started by National Foundation for Cancer Research (NFCR) Youth Ambassador Ally Minker.

Inspired by the passing of her grandfather, Ally took it upon herself to motivate others and advance the cause towards a cure for cancer by involving as many baseball teams as possible. Baseball was one of her granfather’s greatest passions and he imparted that to Ally. So naturally, she turned to the community he loved so much to honor his memory.Primary_Logo_Color

This year, teams in the Carolina League as well as the Quad City River Bandits have heeded Ally’s call and committed games to the Play4TheCure mission. The growth of the program within the sport of baseball is a testament to Ally’s dedication to serving others and saving lives through cancer research.

Here’s a list of teams participating this year:

  • Wilmington Blue Rocks – 7/30/16 – 7:05 PM vs. Frederick Keys – BUY TICKETS and be sure to use promo code “PLAY” | $2 for every ticket sold will go to support cancer research
  • Quad Cities River Bandits (Davenport, IA) – 8/7/16 – 1:15 PM vs. Burlington Bees
  • Ft. Myers Miracles – 8/11/16 – 7:05 PM – vs. Charlotte Stone Crabs
  • Frederick Keys – 8/16/16 – 6:00 PM – vs. Lynchburg Hillcats
  • Charlotte (FL) Stone Crabs – 8/20/16 – 6:05 PM – vs. Bradenton Marauders
  • Tampa Yankees – 8/27/16 – 6:35 PM – vs. Brevard County Manatees
Read more

Be Like Amos – Our 9 Year Old Philanthropist

The NFCR staff was touched by this very special donation. Read his story and share it freely with others. It made our day and we hope it makes yours as well. Meet Amos, our now famous, 9 year old Philanthropist:

photo of Amos. Our 9 year old philanthropist Amos_Porter

From left to right: Arlo (5), Amos (9), and Phil

Less than one year ago, Amos’ father, Phil, experienced a sore throat and noticed a spot on the back of his throat. Phil went to see his general practitioner as well as an ENT doctor who made the diagnosis, tonsillar cancer.  Phil received extraordinary treatment from his surgical team at UPENN followed by thirty treatments of proton radiation therapy to beat his cancer.

A member of a close-knit family, Amos is a sociable, spirited, great boy who loves to wrestle, ride his bike and swim.  He just celebrated his ninth birthday at a local pool.  In place of gift-giving, the family thought they could help make a difference.  Amos asked his friends to contribute to the National Foundation for Cancer Research in honor of his father’s successful battle with cancer.  He collected an impressive $130.00 that became $260.00 since it was received during the NFCR Matching Gift Campaign!

Amos, his parents and his little brother, Arlo, decided to donate to NFCR “since they research all types of cancers and they have a great reputation.”

Amos is proud to help fund NFCR because his father benefited so much from cancer research! Phil is doing very well now and gives credit to his doctors and his family.

NFCR salutes Amos for his generosity and compassion!  This generosity also says a lot about his family. The world needs more 9 year olds like Amos. What a wonderful family. What a wonderful heartfelt gift.

Please share this story – you can make a difference with this one simple act.  Use and spread the cheer. Also you can  Be like Amos and make a difference. Donate here. 

AN UPDATE: AUGUST 18, 2016BeLikeAmos cancer research screen capture 1000 views

With permission from Amos and his family, we shared this post on FaceBook and Twitter. Today, BeLikeAmos has now just exceeded ONE THOUSAND  views – making it one of the most popular posts at NFCR. With all the strife and shouting out there in the world ….isn’t it time for more of us to Be Like Amos- and quietly make a difference.Every voice and every donation – big and small – makes a difference. Thank you Amos and thanks family and friends and donors. By funding Cancer Research, you are helping to save lives!

Read more

Cancer Prevention for Asian American Women

NFCR President Sujuan Ba, Ph.D., delivered an address to the National Association of Professional Asian American Women (NAPAW) about the importance of cancer research and cancer prevention education.

cancer prevention and the logo of National Association of Professional Asian-American Women As an Asian American herself, Dr. Ba is acutely aware of the cancer risks in the Asian American women’s community.  She knows “there are many types of cancer that disproportionately affect women of Asian descent. Education and research are important tools that can provide a number of immediate solutions And, if if widely implemented, would go a long way towards reversing this trend.”  For more than 43 years, The National Foundation for Cancer Research has worked diligently in its mission to raise awareness, educate the public and financially support the work of cancer research scientists. NFCR helps insure translational medicine success. This bench to bedside approach is unique in American Cancer Charities. NFCR is among only a tiny handful of cancer research charities that funds chemists and lab scientists to put an end to all cancers.

The cause of and prevalence of cancer in Asian American women is believed to be both environmental and behavioral. Western diets, in particular, have been widely documented as a major contributing factor in increased cancer diagnoses. In the slideshow, you’ll find more information about cancer prevention tips, new cancer research and actions you can take to help prevent breast cancer, skin cancer, cervical cancer. There are also tips on how you can help prevent lung, prostrate and liver cancer. Men and women can benefit from the cancer prevention tips provided by NFCR and Dr. Sujuan Ba.

The statistics are staggering. Cancer is the number one killer of Asian American Women since 1980. Breast Cancer is the most commonly diagnosed cancer. Breast cancer is the second leading cause of cancer deaths. The incidence and death rates of liver cancer among all Asian Americans is twice as high as those among Caucasians. Liver cancer is the second leading cause of cancer deaths in Asian American men and the fifth leading cause of death among Asian American women.

Dr. Ba presented these slides as she gave a talk to the National Association of Professional Asian American Women’s meeting at the US Department of Health and Human Services, in Washington D.C. in June of 2016. For more information on ways you can support cancer research and to see the full range of educational and cancer research programs, visit

Click on the slide below to enlarge the presentation on cancer risks and prevention.

Read more

National Foundation for Cancer Research and KEW, Inc. announce a collaboration

National Foundation for Cancer Research and KEW, Inc. announce a collaboration to increase awareness of the value of genetic testing.

photo Tuan Ha-Ngoc, KEW & Franklin Salisbury NFCRBig Data comes to Cancer Care Choices.  #Research4aCure

BETHESDA, Maryland (June 8, 2016)  – The National Foundation for Cancer Research (NFCR) and Kew, Inc, a private oncology services company based in Cambridge, Massachusetts , announced today they will jointly work to increase the awareness of the clinical benefits of genetic testing to cancer patients and oncologists.  Precision medicine moves information faster to where the patient decisions are made, thereby potentially improving options, quality of care and potential outcomes as well.

The genetic testing technology, including Next-Gen Sequencing (NGS) on comprehensive and specific gene panels, is able to identify patient-specific drug targets and cancer-driving molecular pathways. Guided by the genetic testing results, oncologists can prescribe personalized and targeted cancer therapies to their patients.

With numerous new drugs that target specific cancer mutations in clinical trials, the ability to share information widely becomes an increasingly burdensome task. NFCR and KEW are teaming up to launch programs that aim to increase the awareness of the value of genetic testing, educate patients, family members and oncologists about the clinical benefits of testing and guide them through the seemingly complex clinical process in a much easier manner.

Raju Kucherlapati, MD, Paul C. Cabot Professor of Genetics and Professor of Medicine, Harvard Medical School and co-founder of KEW, spoke of the goal of “helping doctors everywhere, treat cancer patients anywhere.” “We are dedicated to empowering oncologists to make the right therapy decision for patients by providing actionable, patient-specific information derived from our genetic testing”, said Dr. Kucherlapati.

“KEW’s genetic testing technology and capability in bioinformatics will help to integrate data accumulated from various research and clinical sources into treatment options and cancer care choices, which is highly beneficial to cancer patients and in keeping with NFCR’s long valued efforts in sharing information among scientists, physicians and patients,” said NFCR Chief Science Officer, Michael Wang, MD, PhD.

Public outreach and education is one of the core missions of NFCR’s programs. For more than 43 years, NFCR has been supporting cancer research laboratories and then sharing results with oncologists, patients, and general public worldwide. Many of the NFCR-funded scientists have contributed to developing the foundation of today’s personalized targeted therapies and precision medicine.

NFCR welcomes KEW’s support of the education and communication facet of its mission. Together both organizations can help raise awareness of new options in cancer treatment.

NFCR is a convener and one of the early funders of applying genetic testing technology, including Next-Gen Sequencing (NGS) to clinical applications to guide personalized treatment for patients. With today’s internet speed of access, NFCR is taking fast actions to promote collaboration and information-sharing. NFCR is dedicated to supporting “high risk/high reward” cancer research and public education relating to prevention, early diagnosis, better treatments and, ultimately, a cure for all types of cancer.

For more information:; 301-654-1250

KEW, Inc. provides comprehensive genomic testing services that enable oncologists to make evidence-driven personalized treatment decisions for cancer patients. Based out of Cambridge, MA, KEW was founded by pioneers of the precision medicine industry, including key contributors to the Human Genome and The Cancer Genome Atlas projects. The CANCERPLEX® suite of products offers flexible panel sizes, the largest of which sequences 400+ cancer genes in solid tumors that are the most relevant to oncology patient care. Specialized panels offer the option to test based on the site of a patient’s tumor or to limit results to FDA-approved therapies. CANCERPLEX not only makes personalized medicine more accessible, it delivers the promise of precision medicine for all.

For more information:; 617-229-5954

KEW, Inc.
Mark D. Myslinski
Keith Spiro

Read more

The First Successful Clinical Trial

Clinical Trial and translational medicine. Our CEO and son of the Founder of NFCR likes to talk history. Franklin C. Salisbury, Jr. notes the coincidence, perhaps, that the Salisbury name has long been associated with unheralded basic research that leads to major breakthroughs. Clinical trial and translational medicine –  bring work from lab to patient bedside and is not really a new trend.

HMS Salisbury site of first clinical trialThe HMS Salisbury was a 50 gun British Warship, built at East Cowes, Isle of Wight and launched  on January 29, 1746.  James Lind was the Royal Navy surgeon who studied treatments for scurvy “on board the Salisbury at sea” in 1747.1747 year of the first ever clinical trial

We all remember the story that lemons and oranges cured scurvy and was discovered aboard a navy vessel  but who besides our Franklin would think to connect HMS Salisbury with clinical trials done today. And yet, the comparison is an important one.

The Salisbury  was said to have some 30-40 members of the crew afflicted by scurvy.  “Yet the roll call shows at most one or two as sick during this entire voyage on which six men “departed this life”. This suggests a culture of official denial of sickness at sea, one of many possible reasons, perhaps, why Lind’s work was neglected says Graham Sutton in his essay James Lind aboard Salisbury (Sutton G (2004) James Lind aboard Salisbury)

Official Denial is an interesting phrase. One perhaps that has a place today in our world of blockbuster breakthroughs.There is an interesting bridge between Salisbury, Scurvy, Citrus, Vitamin C and the cancer research supported by NFCR. That connection is Albert Szent-Györgyi.

He was the co-founder of NFCR along with Franklin Salisbury’s dad. Szent-Györgyi was credited with discovering Vitamin C and received the Nobel Prize in 1937. He went on to state his belief that” Cancer is a disease that can be cured,” and the rest is history. For more than 43 years NFCR has been supporting basic lab research into the causes, prevention and treatment of cancer.  The Albert Szent-Györgyi Prize for Progress in Cancer Research is named in honor of Doctor Albert Szent-Györgyi and is a symbol of NFCR’s enduring commitment to uphold Dr. Szent-Györgyi’s vision of curing cancer through innovation and collaboration.

NFCR funded scientists can attest to the need for long term support of basic research. Today’s breakthroughs are often the result of decades of meticulous work built on the work of previous generations. Clinical trial make a difference.   The two men on board the Salisbury that were assigned to the citrus fruit treatment recovered. So too is our hope that those who participate in today’s clinical trials are the lucky ones.


Read more

CFC – Combined Federal Campaign

NFCR_CFC CFC combined federal campaign logo

It’s never too soon to think about the Combined Federal Campaign CFC annual fall drive. If you’d like to volunteer to help us spread the word contact Elaine here or call 301-654-1250

Our 5 digit code is 11267     Our EIN is 04-253 1031

The National Foundation for Cancer Research has been a long standing active charity on the CFC.  We work diligently to insure that seed funding reaches promising, incredibly hard working cancer research scientists. And, If you are a federal employee of  Asian American descent, or have friends who are, please refer them to a presentation by Dr. Sujuan Ba and check out for yourself, NFCR’s cancer prevention tips within her slideshow presentation. These cancer prevention tips are universal in value.

Donations via CFC help. We have a Science Advisory Board (SAB) that insures the most promising work gets funding. We track and highlight their results in our annual report and news updates. This SAB is also responsible for the coveted annual award of the Albert Szent-Györgyi Prize for Progress in Cancer Research

Here’s last year’s snapshot of our page on your CFC Charity Finder Page:

NFCR approved CFC listing

As a leading charity driving donations to #Research4aCure NFCR knows how painstakingly difficult this work is.

We are so proud that the CFC has been allowing Federal employees to direct funds to cancer research charities since our earliest days. Your parents donations are what delivered the breakthroughs that you hear about today. These terms you see in the news, like moonshot, precision medicine and genome (gene) sequencing start in laboratories like the ones we fund. The money you donate today can see results that will help your children and grandchildren in the future.

Speaking of kids, NFCR has a signature program called Play4TheCure  This is a program that promotes teamwork and youth sports to raise funds for research. Parents and kids can organize their team to dedicate a single game or a whole season to raising awareness and funds for Research. The kids can only do so much – so give us a call if you’d like to organize a game for your group.

We also have specific designation programs you might want to consider in or outside of the CFC:

Honor and Remember                  Donate a no longer needed car

Thank you for your consideration and support.

Read more

Green Goddess: Healthy Anti-Cancer Smoothie Recipe



Eating a colorful diet is a good way to make sure you’re getting a variety of vitamins and nutrients that can help prevent cancers. This recipe mixes a few colors from the rainbow and ends up with the “G” in ROY G BIV.

The green goddess smoothie adds a variety of superfoods to your day; you’ll get vitamins, minerals, enzymes, fiber and antioxidants in this delicious drink.

Serves approximately 4 cups

  • 2 cups of purified water
  • 5 cups of spinach leaves
  • ½ lemon squeezed
  • 1 frozen banana
  • 1 granny smith apple
  • 1 ripe pear
  • (Optional) berries and/or a splash of your favorite juice or cider


  1. In a high speed blender, add all ingredients
  2. Pulse for 2-3 minutes or until items are liquefied


Read more